Neurovisual Impairment: A Frequent Complication of
Alpha-Interferon Treatment in Chronic Viral Hepatitis
 Fig. 4. P100 latencies, (A) before and (B) at the end
of interferon treatment, plotted against patients' age. Data from
74 eyes (45 patients) with normal pretreatment visual evoked
responses. (B) Note the steep increases of P100 latency in patients
past the 5th decade of age at the end of interferon therapy only.
Curves represent a best fitted cubic regression line ± 95%
confidence intervals.
Return To Article
|
